InvestorsHub Logo
Followers 11
Posts 116
Boards Moderated 0
Alias Born 02/15/2010

Re: AccipiterQ post# 243

Friday, 07/01/2011 4:12:40 PM

Friday, July 01, 2011 4:12:40 PM

Post# of 16750
>>That's the thing, they shouldn't be low in cash, we covered this last time they diluted a few weeks ago, that they should've had enough cash for another 8 or 9 months. There was a thread on the yahoo board, check it out.

It may have been covered on the YMB, but I don't agree with the analysis. I think they only had cash through about Sep/Oct. So unless they got a license immediately from the interim results, they'd be scraping the barrel again and the partner could play hardball.

Now they have cash on hand for an extra 3-5 months. Less need, more options. Also, if they don't enroll/hit 190 PFS for another 3-5 weeks, I could see the SP slump under $3 again. They get cash in hand with this deal.

>>What could be the reasons that they would suddenly need more cash? Good or bad

They said in the PR the proceeds could go "for general corporate purposes, including the funding of the clinical development of its product pipeline of cancer drugs."

I believe they are using this to get the liver mets trial going the absolute second that HEAT finishes enrolling. Possibly the RCW ph2 trial also.